Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963380 | Vaccine | 2015 | 8 Pages |
Abstract
A total of 100,332 pregnant women were eligible for the analysis. Of these, 2003 (2.0%) received the A/H1N1 pandemic influenza vaccination during the second or third trimester of gestation. We did not observe any statistically significant association between the A/H1N1 pandemic influenza vaccination and different maternal outcomes (hospital admissions for influenza, pneumonia, hypertension, eclampsia, diabetes, thyroid disease, and anaemia), fetal outcomes (fetal death after the 22nd gestational week) and neonatal outcomes (pre-term birth, low birth weight, low 5-min Apgar score, and congenital malformations). Pre-existing health-risk conditions (hospital admissions and drug prescriptions for specific diseases before the onset of pregnancy) were observed more frequently among vaccinated women, thus suggesting that concomitant chronic conditions increased vaccination uptake. The results of this study add some evidence on the safety of A/H1N1 pandemic influenza vaccination during pregnancy but, because of the reduced statistical power, meta-analyses and large multi-centres studies are needed in order to obtain more conclusive results, especially for rare outcomes.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Massimo Fabiani, Antonino Bella, Maria C. Rota, Elena Clagnan, Tolinda Gallo, Maurizio D'Amato, Patrizio Pezzotti, Lorenza Ferrara, Vittorio Demicheli, Domenico Martinelli, Rosa Prato, Caterina Rizzo,